WO1996003435A3 - FELINE η-INTERFERON - Google Patents

FELINE η-INTERFERON Download PDF

Info

Publication number
WO1996003435A3
WO1996003435A3 PCT/GB1995/001731 GB9501731W WO9603435A3 WO 1996003435 A3 WO1996003435 A3 WO 1996003435A3 GB 9501731 W GB9501731 W GB 9501731W WO 9603435 A3 WO9603435 A3 WO 9603435A3
Authority
WO
WIPO (PCT)
Prior art keywords
interferon
feline
recombinant
polynucleotide fragment
recombinant vector
Prior art date
Application number
PCT/GB1995/001731
Other languages
French (fr)
Other versions
WO1996003435A2 (en
Inventor
David Edward Onions
David Argyll
Gillian Margaret Lees
Original Assignee
Q One Biotech Ltd
David Edward Onions
David Argyll
Gillian Margaret Lees
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Q One Biotech Ltd, David Edward Onions, David Argyll, Gillian Margaret Lees filed Critical Q One Biotech Ltd
Priority to AU30831/95A priority Critical patent/AU3083195A/en
Publication of WO1996003435A2 publication Critical patent/WO1996003435A2/en
Publication of WO1996003435A3 publication Critical patent/WO1996003435A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention provides a polynucleotide fragment encoding feline η-interferon, a recombinant vector comprising such a polynucleotide fragment, a host cell containing said polynucleotide fragment or recombinant vector, a recombinant feline η-interferon polypeptide, and pharmaceutical compositions comprising recombinant η-interferon for use as a prophylactic and/or therapeutic agent and also as an adjuvant.
PCT/GB1995/001731 1994-07-21 1995-07-21 FELINE η-INTERFERON WO1996003435A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU30831/95A AU3083195A (en) 1994-07-21 1995-07-21 Feline gamma-interferon

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9414752.7 1994-07-21
GB9414752A GB9414752D0 (en) 1994-07-21 1994-07-21 Feline gamma-interferon

Publications (2)

Publication Number Publication Date
WO1996003435A2 WO1996003435A2 (en) 1996-02-08
WO1996003435A3 true WO1996003435A3 (en) 1996-05-02

Family

ID=10758694

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1995/001731 WO1996003435A2 (en) 1994-07-21 1995-07-21 FELINE η-INTERFERON

Country Status (3)

Country Link
AU (1) AU3083195A (en)
GB (1) GB9414752D0 (en)
WO (1) WO1996003435A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3845915B2 (en) * 1996-10-31 2006-11-15 東レ株式会社 Cat atopic dermatitis therapeutic agent and method of treatment
GB9704977D0 (en) * 1997-03-11 1997-04-30 Univ Glasgow FIV vaccine
US7078512B2 (en) 1998-05-01 2006-07-18 Schering-Plough Animal Health Corporation Nucleic acid encoding feline CD86
US7279168B2 (en) 1998-05-01 2007-10-09 Texas A & M University System Recombinant virus expressing foreign DNA encoding feline CD86 and uses thereof
CN112717123A (en) * 2020-12-29 2021-04-30 泰州博莱得利生物科技有限公司 Cat nose drops and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3642096A1 (en) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int HORSE (GAMMA) INTERFERON

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3642096A1 (en) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int HORSE (GAMMA) INTERFERON
EP0271824A2 (en) * 1986-12-10 1988-06-22 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Horse gamma interferon

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ARGYLE D.J. ET AL.: "Nucleotide and predicted peptide sequence of feline interferon-gamma", DNA SEQUENCE, vol. 5, no. 3, pages 169 - 171 *
KHAN K.N.M. ET AL.: "Synergistic effects of Tumour Necrosis Factor-alpha and Interferon-gamma on Feline haematopoietic progenitors", COMP. HAEMATOL. INT., vol. 2, no. 2, pages 79 - 83 *
YASUDA M. ET AL.: "Partial purification and characterization of feline gamma-like Interferon", PREP. BIOCHEM., vol. 16, no. 3, pages 217 - 226 *

Also Published As

Publication number Publication date
WO1996003435A2 (en) 1996-02-08
AU3083195A (en) 1996-02-22
GB9414752D0 (en) 1994-09-07

Similar Documents

Publication Publication Date Title
WO1996017072A3 (en) Recombinant alphavirus vectors
WO1995007994A3 (en) Recombinant alphavirus vectors
IL130102A (en) Aminoguanidines and alkoxyguanidines as protease inhibitors, pharmaceutical compositions containing the same and processes for preparing the same
EP0962467A4 (en) Antibody against human parathormone related peptides
WO2001053455A3 (en) Novel nucleic acids and polypeptides
AUPP051497A0 (en) Antimicrobial peptides
AU6743294A (en) Xylanase derived from a bacillus species, expression vectors for such xylanase and other proteins, host organismstherefor and use thereof
IE830161L (en) Multifunctional cloning vectors
AU7406694A (en) Novel b. burgdorferi polypeptides
AU2764997A (en) Udp-(n)-acetyl-alpha-d-galactosamine:polypeptide (n)-acetylgalactosaminyltransferase, galnac-t3
EP0684834A4 (en) Microemulsions comprising therapeutic peptides.
EP0684833A4 (en) Microemulsions comprising therapeutic peptides.
WO1996003435A3 (en) FELINE η-INTERFERON
CA2204151A1 (en) Cdna encoding a bmp type ii receptor
AU7401898A (en) Safety Valve for an Inverted Liquid-filled canister
AU6292694A (en) Novel polypeptide, dna coding for said polypeptide, recombinant vector containing said dna, recombinant virus prepared using said vector, and use thereof
AU6063900A (en) Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
WO1994016085A3 (en) Hybrid proteins having cross-linking and tissue-binding activities
WO1996003436A3 (en) EQUINE η-INTERFERON
AU1440695A (en) P53-based polypeptide fragments, nucleic acid molecules encoding same, and uses thereof
WO1997005251A3 (en) Feline stem cell factor
EP0911409A3 (en) Deformylase
UA42741C2 (en) Peptide of mastitis vaccine (variants), the peptide of complex antigenic idea (variants), pharmaceutical composition (variants)
AU4505099A (en) (moraxella catarrahalis) polynucleotides and polypeptides
WO2000070036A3 (en) Genes expressed in hippocampus

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase